Citation Impact
Citing Papers
Interventions to improve outpatient referrals from primary care to secondary care
2008
Network meta-analysis: simultaneous meta-analysis of common antiplatelet regimens after transient ischaemic attack or stroke
2008
The GRAIDS Trial: a cluster randomised controlled trial of computer decision support for the management of familial cancer risk in primary care
2007
Depression
2018 Standout
Osteosarcoma incidence and survival rates from 1973 to 2004
2009 Standout
Systematic review and economic modelling of effectiveness and cost utility of surgical treatments for men with benign prostatic enlargement
2008
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma: 2015 Update
2015 Standout
Rheumatoid arthritis
2016 Standout
Phase II study of liposomal cisplatin (Lipoplatin™) plus gemcitabine versus cisplatin plus gemcitabine as first line treatment in inoperable (stage IIIB/IV) non-small cell lung cancer
2009
Development of a new G-CSF product based on biosimilarity assessment
2009
Administration of Cisplatin-Based Chemotherapy for Advanced Urothelial Carcinoma in the Community
2012
Evaluation of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis of Colorectal Origin in the Era of Value-Based Medicine
2016
A systematic review and meta-analysis on the oncological long-term outcomes after trimodality therapy and radical cystectomy with or without neoadjuvant chemotherapy for muscle-invasive bladder cancer
2017
Comparative effectiveness and safety of biological treatment options after tumour necrosis factor α inhibitor failure in rheumatoid arthritis: systematic review and indirect pairwise meta-analysis
2012
Update on Prevalence of Pain in Patients With Cancer: Systematic Review and Meta-Analysis
2016 Standout
Nivolumab in metastatic urothelial carcinoma after platinum therapy (CheckMate 275): a multicentre, single-arm, phase 2 trial
2017 Standout
First-line pembrolizumab in cisplatin-ineligible patients with locally advanced and unresectable or metastatic urothelial cancer (KEYNOTE-052): a multicentre, single-arm, phase 2 study
2017 Standout
Value of a national administrative database to guide public decisions: From the système national d’information interrégimes de l’Assurance Maladie (SNIIRAM) to the système national des données de santé (SNDS) in France
2017 Standout
Nutzbarkeit von Datenbanken in der Gesundheitsökonomie
2005
A role for neoadjuvant gemcitabine plus cisplatin in muscle‐invasive urothelial carcinoma of the bladder
2008
Osteosarcoma treatment – Where do we stand? A state of the art review
2013 Standout
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines
2020 Standout
Radiotherapy with or without Chemotherapy in Muscle-Invasive Bladder Cancer
2012
Survival Time Outcomes in Randomized, Controlled Trials and Meta-Analyses: The Parallel Universes of Efficacy and Cost-Effectiveness
2011
French national health insurance information system and the permanent beneficiaries sample
2010 Standout
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
2009 Standout
Osteosarcoma of the Mobile Spine
2011
2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours
2010 Standout
Critical Analysis of Bladder Sparing with Trimodal Therapy in Muscle-invasive Bladder Cancer: A Systematic Review
2014
Bladder cancer
2016 Standout
Status and perspectives of claims data analyses in Germany—A systematic review
2016 Standout
Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer
2016 Standout
Cisplatin-Ineligible and Chemotherapy-Ineligible Patients Should Be the Focus of New Drug Development in Patients With Advanced Bladder Cancer
2013
Healthcare Databases in Thailand and Japan: Potential Sources for Health Technology Assessment Research
2015
Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan-Meier survival curves
2012 Standout
Soft Tissue Sarcoma: An Update on Systemic Treatment Options for Patients with Advanced Disease
2014
Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial
2010 Standout
Osteosarcoma over the age of forty
2002
Palliative therapy for osteosarcoma
2011
Ethnopharmacological uses, phytochemistry, biological activities, and therapeutic applications of Clinacanthus nutans (Burm. f.) Lindau: A comprehensive review
2017 Standout
Review of deep learning: concepts, CNN architectures, challenges, applications, future directions
2021 Standout
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
2009 Standout
The status of platinum anticancer drugs in the clinic and in clinical trials
2010 Standout
Motor recovery after stroke: a systematic review
2009 Standout
Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: a randomised, open-label, multicentre, phase 3 trial
2016 Standout
Cisplatin and gemcitabine administered every two weeks in patients with locally advanced or metastatic urothelial carcinoma and impaired renal function
2012
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
A study of split-dose cisplatin-based neo-adjuvant chemotherapy in muscle-invasive bladder cancer
2012
Changes in Renal Function Following Nephroureterectomy May Affect the Use of Perioperative Chemotherapy
2010
Formulas Calculating Creatinine Clearance Are Inadequate for Determining Eligibility for Cisplatin-Based Chemotherapy in Bladder Cancer
2006
Phase II Study of Conformal Hypofractionated Radiotherapy With Concurrent Gemcitabine in Muscle-Invasive Bladder Cancer
2011
Deep Learning-Based Image Segmentation on Multimodal Medical Imaging
2019
Bladder Cancer
2020 Standout
Dissemination and publication of research findings: an updated review of related biases
2010 Standout
Decision aids for people facing health treatment or screening decisions
2017 Standout
Liposomal Formulations in Clinical Use: An Updated Review
2017 Standout
Mechanisms of Cisplatin Nephrotoxicity
2010 Standout
Printed educational materials: effects on professional practice and healthcare outcomes
2012 Standout
Study on the improved fuzzy clustering algorithm and its application in brain image segmentation
2019 Standout
Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer
2018 Standout
The Lancet Psychiatry Commission on psychological treatments research in tomorrow's science
2018
The national healthcare system claims databases in France, SNIIRAM and EGB: Powerful tools for pharmacoepidemiology
2017 Standout
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Treatment of Patients With Metastatic Urothelial Cancer “Unfit” for Cisplatin-Based Chemotherapy
2011
Identification and assessment of ongoing trials in health technology assessment reviews
2004
Symptom Burden, Survival and Palliative Care in Advanced Soft Tissue Sarcoma
2011
Works of D. Peake being referenced
Long-term results of a phase II study of synchronous chemoradiotherapy in advanced muscle invasive bladder cancer
2004
Paget′s Osteosarcoma — no Cure in Sight
1999
A phase I/II study of gemcitabine and fractionated cisplatin in an outpatient setting using a 21-day schedule in patients with advanced and metastatic bladder cancer
2004
A phase I–II study of synchronous chemoradiotherapy for poor prognosis locally advanced bladder cancer
2001
Guidelines for the Management of Soft Tissue Sarcomas
2010
Common acute oncological emergencies: diagnosis, investigation and management
2008
Imatinib for the treatment of patients with unresectable and/or metastatic gastrointestinal stromal tumours: systematic review and economic evaluation
2005
A phase II clinical trial of gemcitabine and split dose cisplatin in advanced non-small cell lung cancer in an outpatient setting
2008